Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) Sees Significant Decline in Short Interest

Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) was the recipient of a large drop in short interest in the month of August. As of August 14th, there was short interest totaling 400 shares, a drop of 54.4% from the July 30th total of 877 shares. Currently, 0.1% of the shares of the company are short sold. Based on an average daily trading volume, of 2,137 shares, the short-interest ratio is presently 0.2 days.

Innovator IBD Breakout Opportunities ETF Stock Down 0.2%

Shares of BOUT traded down $0.07 during midday trading on Monday, reaching $44.09. 609 shares of the stock were exchanged, compared to its average volume of 3,763. Innovator IBD Breakout Opportunities ETF has a twelve month low of $35.05 and a twelve month high of $49.41. The company has a market cap of $15.43 million, a P/E ratio of 28.69 and a beta of 1.04. The stock’s 50 day simple moving average is $46.35 and its 200 day simple moving average is $44.14.

Hedge Funds Weigh In On Innovator IBD Breakout Opportunities ETF

Hedge funds have recently bought and sold shares of the business. Comprehensive Wealth Management LLC grew its position in shares of Innovator IBD Breakout Opportunities ETF by 122.0% during the 4th quarter. Comprehensive Wealth Management LLC now owns 23,403 shares of the company’s stock worth $850,000 after purchasing an additional 12,859 shares in the last quarter. Susquehanna International Group LLP increased its holdings in shares of Innovator IBD Breakout Opportunities ETF by 42.6% during the third quarter. Susquehanna International Group LLP now owns 26,176 shares of the company’s stock worth $1,020,000 after purchasing an additional 7,817 shares during the period. Finally, Osaic Holdings Inc. raised its position in shares of Innovator IBD Breakout Opportunities ETF by 39.7% in the second quarter. Osaic Holdings Inc. now owns 2,102 shares of the company’s stock valued at $77,000 after buying an additional 597 shares in the last quarter.

Innovator IBD Breakout Opportunities ETF Company Profile

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator.